Twist Bioscience Corporation (TWST) Financials
TWST Assets vs Liabilities
Date | Assets | Liabilities |
---|---|---|
2023-12-31 | 732.8 million | 142.8 million |
2023-09-30 | 776.4 million | 153.0 million |
2023-06-30 | 810.3 million | 152.8 million |
2023-03-31 | 853.9 million | 150.0 million |
TWST Free Cash Flow and Stock based compensation
Graph available only for supporters. Become a supporter to see it.
Date | Free Cash Flow | Stock based compensation |
---|---|---|
2023-12-31 | -24.5 million | 11.0 million |
2023-09-30 | -23.1 million | 11.7 million |
2023-06-30 | -27.9 million | 10.6 million |
2023-03-31 | -53.3 million | 10.3 million |
TWST Net Income
No data available :(
TWST Cash and Debt
Graph available only for supporters. Become a supporter to see it.
Date | Cash | Debt | Capital Lease |
---|---|---|---|
2023-12-31 | 311.1 million | - | 91.9 million |
2023-09-30 | 336.4 million | - | 94.1 million |
2023-06-30 | 357.1 million | - | 93.0 million |
2023-03-31 | 387.7 million | - | 91.2 million |
TWST Shares Outstanding
TWST Expenses
Graph available only for supporters. Become a supporter to see it.
Date | Capex | R&D | G&A | S&M |
---|---|---|---|---|
2023-12-31 | 1.5 million | 23.1 million | 52.8 million | - |
2023-09-30 | 2.4 million | 23.7 million | 47.4 million | - |
2023-06-30 | 4.5 million | 24.5 million | 46.1 million | - |
2023-03-31 | 9.1 million | 27.4 million | 54.0 million | - |
TWST Cost of Revenue
Graph available only for supporters. Become a supporter to see it.
Date | Revenue | Cost of Revenue |
---|---|---|
2023-12-31 | 71.5 million | 42.5 million |
2023-09-30 | 66.9 million | 42.4 million |
2023-06-30 | 63.7 million | 41.8 million |
2023-03-31 | 60.2 million | 41.7 million |
TWST
Price: $31.96
52 week price:
Earnings Per Share: -3.61 USD
P/E Ratio: -9.57
Exchange: NMS
Sector: Healthcare
Industry: Diagnostics & Research
Volume: 1.1 million
Market Capitalization: 1.9 billion